apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors (2019) Awadalla M, Golden DLA, Mahmood SS, Alvi RM, Mercaldo ND, Hassan MZO, Banerji D, et al. Journal article Predicting the response of uveal melanoma to immunotherapy with MRI assessments (2019) Moreira A, Saake M, Schuler G, Heinzerling L Conference contribution Neurological side effects of checkpoint inhibitors (2019) Knauss S, Roque LG, Huehnchen P, Heinzerling L, Boehmerle W, Endres M Journal article c-Rel is a cell cycle modulator in human melanoma cells (2019) Priebe MK, Dewert N, Amschler K, Erpenbeck L, Heinzerling L, Schoen MP, Seitz CS, Lorenz VN Journal article Merkel Cell Carcinoma of the Head and Neck Compared to Other Anatomical Sites in a Real-World Setting: Importance of Surgical Therapy for Facial Tumors (2019) Kirchberger M, Heppt MV, Schuler G, Berking C, Heinzerling L Journal article Checkpoint Inhibitors (2019) Heinzerling L, De Toni EN, Schett G, Hundorfean G, Zimmer L Journal article Myositis and neuromuscular side-effects induced by immune checkpoint inhibitors (2019) Moreira A, Loquai C, Pfoefer C, Kaehler KC, Knauss S, Heppt MV, Gutzmer R, et al. Journal article Centrosomal protein TRIM43 restricts herpesvirus infection by regulating nuclear lamina integrity (2019) Full F, Van Gent M, Sparrer KMJ, Chiang C, Zurenski MA, Scherer M, Brockmeyer NH, et al. Journal article Phase I dose-escalation and expansion study of intratumoral CV8102, a RNA-based TLR- nd RIG-1 agonist in patients with advanced solid tumors (2018) Terheyden P, Weishaupt C, Heinzerling L, Klinkhardt U, Krauss J, Mohr P, Kiecker F, et al. Conference contribution BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy (2018) Dörrie J, Babalija L, Hoyer S, Gerer KF, Schuler G, Heinzerling L, Schaft N Journal article